CP‐31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s-Reference-Cited by-同舟云学术

CP‐31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s

Published:2018-08-21 Issue:3 Volume:234 Page:2929-2942
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Liu Ling¹,Yu Tan‐Tan¹,Ren Chen‐Chen¹,Yang Li¹,Cui Shi‐Hong¹,Zhang Xiao‐An²^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology The Third Affiliated Hospital of Zhengzhou University Zhengzhou China

2. Department of Imaging The Third Affiliated Hospital of Zhengzhou University Zhengzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27109

Reference40 articles.

1. Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer

2. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer

3. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer;Cao S.;International Journal of Clinical and Experimental Pathology,2014

4. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer

5. Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies;Frontiers in Medicine;2021-07-28

2. A Slug‐dependent mechanism is responsible for tumor suppression of p53‐stabilizing compound CP‐31398 in p53‐mutated endometrial carcinoma;Journal of Cellular Physiology;2020-07-06

3. Potential synergistic effects of sorafenib and CP‑31398 for treating anaplastic thyroid cancer with p53 mutations;Oncology Letters;2020-02-07

4. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents;European Journal of Medicinal Chemistry;2020-01

5. Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells;Journal of Gynecologic Oncology;2019